Results 161 to 170 of about 41,447 (182)

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

New England Journal of Medicine, 1997
François Guilhot, Claude Chastang, Agnes Guerci   +2 more
exaly  

Chronic myelogenous leukemia and sweet syndrome

American Journal of Hematology, 1989
Philip R Cohen, Razelle Kurzrock
exaly  

[Chronic myelogenous leukemia].

Nihon rinsho. Japanese journal of clinical medicine, 2006
In the therapy of chronic myelogenous leukemia (CML), interferon (IFN) brought about a big progress resulting in the good hematologic as well as cytogenetic response and prolongation of survival. Recently, imatinib, the BCR/ABL antagonist, took over the first choice drug of the treatment CML.
openaire   +1 more source

Chronic myelogenous leukemia and benzene exposure: A systematic review and meta-analysis of the case–control literature

Chemico-Biological Interactions, 2009
Steven H Lamm, Arnold Engel, Rusan Chen   +2 more
exaly  

Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia

New England Journal of Medicine, 1986
Moshe Talpaz, Hagop Kantarjian, JOSÉ M Trujillo   +2 more
exaly  

Immunological Effects of Interferon-alpha on Chronic Myelogenous Leukemia

Leukemia and Lymphoma, 2003
Fabiola Attie De Castro, Belinda Pinto Simões   +1 more
exaly  

Role of Interleukin-1 Inhibitory Molecules in Therapy of Acute and Chronic Myelogenous Leukemia

Leukemia and Lymphoma, 1993
Zeev Estrov, Razelle Kurzrock, Moshe Talpaz   +2 more
exaly  

The Role of Interferon in the Treatment of Chronic Myelogenous Leukemia: Results and Prospects

Leukemia and Lymphoma, 1992
Fausto Grignani
exaly  

Advances in treatment of chronic myelogenous leukemia – new treatment options with tyrosine kinase inhibitors

Leukemia and Lymphoma, 2009
Fabio P S Santos, Farhad Ravandi
exaly  

A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia

New England Journal of Medicine, 1994
Robert P Castleberry, Peter D Emanuel, Kenneth S Zuckerman   +2 more
exaly